Clinical Edge Journal Scan

Sustained remission tied to better outcomes than sustained LDA in early RA


 

Key clinical point: Patients with early rheumatoid arthritis (RA) who achieved disease remission and sustained it for 10 years had significantly lower structural progression and functional impairment than those who continued to have low disease activity (LDA).

Major finding: Patients with sustained remission vs sustained LDA had significantly lower mean 10-year structural progression (van der Heijde-modified Total Sharp Score 4.06 vs 14.59; P < .001) and 10-year functional impairment (Health Assessment Questionnaire Disability Index 0.14 vs 0.53; P < .001) scores.

Study details: This study analyzed the data of 252 patients with early RA from the ESPOIR cohort, of whom 48 patients were in sustained remission and 135 patients had sustained LDA.

Disclosures: The ESPOIR cohort was supported by grants from Merck Sharp & Dohme and other sources. The authors declared no conflicts of interest.

Source: Ruyssen-Witrand A et al. Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity. Arthritis Res Ther. 2023;25:207 (Oct 20). doi: 10.1186/s13075-023-03176-7

Recommended Reading

Abatacept reduced rates of progression to RA, phase 2b trial finds
MDedge Rheumatology
Conditional recommendations rule in new SARD-associated interstitial lung disease guidelines
MDedge Rheumatology
Low-dose methotrexate carries higher risk for older patients with CKD
MDedge Rheumatology
Real-world study confirms efficacy of all JAK inhibitors in RA
MDedge Rheumatology
Elevated risk for cancer in RA patients treated with DMARD
MDedge Rheumatology
Herpes zoster subunit vaccine can be recommended in JAKi-treated RA
MDedge Rheumatology
Real-world study demonstrates cons of tapering DMARD in well-controlled RA
MDedge Rheumatology
Two-fold higher risk for serious infections with tofacitinib vs bDMARD in older RA patients
MDedge Rheumatology
Meta-analysis assesses hepatitis B reactivation risk in anti-IL-6-treated RA
MDedge Rheumatology
Four-fold higher risk for interstitial lung abnormalities in RA patients with a history of smoking
MDedge Rheumatology